|
|||||
|
|

Electronic signature company DocuSign (NASDAQ:DOCU) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 8.4% year on year to $818.4 million. The company expects next quarter’s revenue to be around $827 million, close to analysts’ estimates. Its non-GAAP profit of $1.01 per share was 10.4% above analysts’ consensus estimates.
Is now the time to buy DOCU? Find out in our full research report (it’s free for active Edge members).
DocuSign’s third quarter was marked by robust growth in its Intelligent Agreement Management (IAM) platform and steady adoption of core eSignature products, though the market responded negatively to the results. Management attributed the quarter’s performance to increased customer expansion within the IAM platform, particularly among enterprise clients, and cited operational efficiency as a key driver of improved profitability. CEO Allan Thygesen highlighted, “We delivered one of the higher growth quarters over the past 2 years, driven by continued customer investment in core products and the IAM platform.”
Looking ahead, DocuSign’s guidance is built on expectations for sustained IAM adoption, evolving go-to-market strategies, and ongoing platform innovation. Management noted plans to focus on broader department and enterprise-wide deployments, enhanced product features, and ecosystem integrations to maintain momentum. CFO Blake Grayson emphasized the importance of balancing growth with disciplined investment, stating, “We project quite modest headcount growth… investing carefully in the places that give us the most leverage over time.”
Management credited IAM platform momentum, improved retention, and operational discipline as essential to recent and forward-looking performance.
DocuSign’s outlook is shaped by IAM adoption trends, deeper enterprise engagement, and ongoing investment in AI-driven product enhancements.
Our analyst team will monitor (1) the pace of IAM adoption and expansion within large organizations, (2) the rollout and customer uptake of new AI-powered features such as Agreement Desk and contract agents, and (3) the impact of international growth initiatives, especially in Asia-Pacific markets. Additional focus will be given to DocuSign’s ability to sustain operational efficiency and manage the transition to ARR-based reporting.
DocuSign currently trades at $68.87, down from $71.10 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free for active Edge members).
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
| Dec-23 | |
| Dec-22 | |
| Dec-20 | |
| Dec-17 | |
| Dec-17 | |
| Dec-17 | |
| Dec-17 | |
| Dec-15 | |
| Dec-12 | |
| Dec-11 | |
| Dec-11 | |
| Dec-11 | |
| Dec-10 | |
| Dec-09 | |
| Dec-08 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite